Skip to main content

Hannover Re buys Scottish portfolio

Ulrich Wallin

Hannover Re has agreed to buy a reinsurance portfolio from Scottish Re (US).

The acquired portfolio covers the mortality risk under term life and endowment policies that were reinsured by Scottish Re in the underwriting years 2000 to 2003.

The business is 100% assumed by Hannover Re with effect from 1 January 2011.

Hannover Re said the business is expected to generate an annual premium volume of about $80m. The reinsurer assumes the technical liabilities associated with the portfolio and will in return receive the necessary assets from Scottish Re.

Ulrich Wallin, chief executive officer of Hannover Re, said: "This transaction superbly complements our acquisition of the ING life reinsurance portfolio in 2009 and further strengthens our traditional US life business".

The transaction is expected to close in May 2011 and still requires regulatory approval.

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@postonline.co.uk or view our subscription options here: https://subscriptions.postonline.co.uk/subscribe

You are currently unable to copy this content. Please contact info@postonline.co.uk to find out more.

Diary of an Insurer: Swiss Re’s Leo Dixon

From winter storm-driven flight delays, to early morning sea-air walks in Poole and artificial intelligence-driven Claims Reimagination sessions, Leo Dixon, global head of claims for property and casualty reinsurance at Swiss Re, shares why there’s no such thing as a typical week in claims.

Big Interview: Tom Clementi, Pool Re

Tom Clementi, CEO of Pool Re, speaks to Insurance Post regarding his efforts to modernise the government-backed reinsurer, how terror risk has evolved, and where the firm sits on cyber.

Most read articles loading...

You need to sign in to use this feature. If you don’t have an Insurance Post account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here